Cargando…
Dendritic Cell-Based Immunotherapies and their Potential use in Colorectal Cancer Immunotherapy
Dendritic cells (DCs) are professional antigen-presenting cells, which are resident or proliferating in organs. Major histocompatibility complex (MHC) Class I and II on DCs in normal steady conditions process and present antigens including cancer antigens. Many approaches are used to enhance antigen...
Autores principales: | Aldahlawi, Alia M., Abdullah, Samaa Taha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728090/ https://www.ncbi.nlm.nih.gov/pubmed/36504589 http://dx.doi.org/10.4103/jmau.jmau_20_21 |
Ejemplares similares
-
Immune Dysfunctions and Immunotherapy in Colorectal Cancer: The Role of Dendritic Cells
por: Gessani, Sandra, et al.
Publicado: (2019) -
Modulation of dendritic cell immune functions by plant components
por: Aldahlawi, Alia M.
Publicado: (2016) -
Dendritic Cell-Based Immunity: Screening of Dendritic Cell Subsets in Breast Cancer-Bearing Mice
por: Aldahlawi, Alia M, et al.
Publicado: (2023) -
Dendritic Cell-Based Immunotherapy for Prostate Cancer
por: Jähnisch, Hanka, et al.
Publicado: (2010) -
Plasmacytoid Dendritic Cells and Cancer Immunotherapy
por: Fu, Chunmei, et al.
Publicado: (2022)